AXPH fundamentals
ALEXANDRIA PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss
The total revenue of AXPH for the last quarter is 511.08 M EGP, and it's 0.17% lower compared to the previous quarter. The net income of Q3 24 is 54.07 M EGP.
Q3 '15
Q4 '15
Q1 '16
Q3 '16
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q3 '22
Q1 '23
Q2 '23
Q1 '24
Q2 '24
Q3 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EGP
Q3 '15
Q4 '15
Q1 '16
Q3 '16
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q3 '22
Q1 '23
Q2 '23
Q1 '24
Q2 '24
Q3 '24
TTM